Computational approaches in target identification and drug discovery

Area of Science:

• Biomedical Informatics
• Drug Discovery
• Computational Biology

Background:

• The increasing volume and diversity of data in the big data era are transforming biomedical research.
• New technologies and open data initiatives have significantly expanded datasets available for analysis.
• Big data analytics are integral to various stages of the drug discovery pipeline.

Purpose of the Study:

• To review computational tools and databases for leveraging big data in drug discovery.
• To highlight the application of big data across the entire drug discovery process.
• To propose a synergistic approach for cost-effective big data utilization in personalized medicine.

Main Methods:

• Review of existing computational tools and databases.
• Discussion of big data applications in target identification, mechanism of action studies, and lead identification.
• Exploration of the integration of information technologies and cheminformatics.

Main Results:

• Big data analytics are crucial for hypothesis validation and discovery in biomedicine.
• A wide array of computational tools and databases are available for big data analysis.
• Synergistic integration of IT and cheminformatics can enhance cost-effectiveness.

Conclusions:

• Big data analytics are essential for modern drug discovery and biomedical research.
• Effective utilization of big data requires appropriate computational tools and databases.
• Combining information technologies with cheminformatics is key to advancing personalized medicine cost-effectively.